Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07120217) titled 'Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on =200 Adult Female HL Patients Treated With =1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment' on Aug. 1.
Study Type: Observational
Primary Sponsor: Federico II University
Condition:
Hodgkin Disease
Breast Cancer
Liposomal Doxorubicin
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2008
Target Sample Size: 200
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07120217
Published by HT Digita...